Lacey David L. 4
4 · Arcus Biosciences, Inc. · Filed Jan 27, 2025
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-23+5,000→ 5,000 totalExercise: $13.33Exp: 2035-01-22→ Common Stock (5,000 underlying)
Holdings
- 57,652
Common Stock
Footnotes (1)
- [F1]The option is exercisable in 24 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.